Armaron Bio Pty Ltd
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction (NCT02557217) | Armaron Bio Pty Ltd | 2015-10-01 |
Track Armaron Bio Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.